title: Improved diabetes control reduces skeletal muscle capillary basement membrane width in insulin-dependent diabetes mellitus.
abstract: We studied the relationship between the control of blood glucose and the width of skeletal muscle capillary basement membrane in 54 insulin-dependent diabetic patients. After initial measurement of levels of glycosylated hemoglobin and the width of skeletal muscle capillary basement membrane, the patients were divided into two groups: an intensive treatment group of 30 patients who were treated with continuous subcutaneous insulin infusion and a control group of 24 patients who continued to receive conventional treatment, usually two daily injections of insulin. Both groups have been followed prospectively for periods of time up to 4 years. Within 1 year the intensive treatment group had a significant decrease in glycosylated hemoglobin levels as compared to baseline values reflecting improved control of blood glucose. This level of glycosylated hemoglobin was stable over the remainder of the follow-up period. This group also had a significant reduction in the width of skeletal muscle capillary basement membrane within 1 year and it persisted for the 4 years of observation. The control group of patients had no significant change in their level of glycosylated hemoglobin and the width of the skeletal muscle capillary basement membrane tended to increase with time. It this result in skeletal muscle capillaries applies to those of retinal and renal tissue, meticulous diabetic control for a prolonged period of time may be beneficial in preventing the progression of the microvascular complications of diabetes mellitus.
authors: Department of Internal Medicine, University of Texas Health Science Center, Dallas.
authors: J
authors: J
authors: Rosenstock
authors: P
authors: P
authors: Challis
authors: S
authors: S
authors: Strowig
authors: P
authors: P
authors: Raskin
mesh_terms: D000328:Adult; D001485:Basement Membrane / Q000473:pathology; D002196:Capillaries / Q000473:pathology*; D003922:Diabetes Mellitus, Type 1 / Q000473:pathology* / Q000628:therapy; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D009132:Muscles / Q000098:blood supply
chemical_list: D006442:Glycated Hemoglobin